|
| Full Name | Piezo Type Mechanosensitive Ion Channel Component 2 |
| Chromosome | 18p11.22 |
| NCBI Gene ID | 63895 |
| Ensembl ID | ENSG00000154864 |
| OMIM ID | 613629 |
| UniProt ID | Q9H5I5 |
| Associated Diseases | Distal Arthrogryposis Type 5, Gordon Syndrome, Marden-Walker Syndrome, Hereditary Sensory Neuropathy |
PIEZO2 encodes the principal mechanosensitive ion channel responsible for light touch sensation and proprioception in the mammalian nervous system. PIEZO2 is a remarkably large trimeric transmembrane protein that directly converts mechanical force into electrical signals, functioning as the molecular basis of gentle touch, vibration detection, and body position sense. The discovery of PIEZO channels by Ardem Bhattacharyya (Patapoutian) and colleagues earned the 2021 Nobel Prize in Physiology or Medicine.
PIEZO2 is relevant to neurodegeneration because its dysfunction causes inherited sensory and motor neuropathies, and because mechanosensitive signaling pathways influence neuroinflammation, neuronal survival, and glial activation. Gain-of-function mutations cause distal arthrogryposis syndromes, while loss-of-function mutations cause a distinctive syndrome of absent proprioception and touch insensitivity. PIEZO2's expression in dorsal root ganglia sensory neurons, Merkel cells, and proprioceptors positions it at the interface between sensory processing and neurodegeneration.
¶ Gene Structure and Expression
PIEZO2 is located on chromosome 18p11.22 and spans approximately 430 kb, one of the largest genes in the genome. It encodes a 2822-amino acid protein that forms functional homotrimeric channels. Each subunit contains:
- Extracellular blade domains (N-terminal region): 38 transmembrane helices arranged as peripheral "propeller blades" that sense membrane tension and curvature
- Anchor domain: Links the mechanosensing blades to the pore module
- Central pore module: Three inner helices from each subunit form a cation-selective ion channel pore
- C-terminal extracellular domain (CED): Contains the selectivity filter and is accessible for pharmacological modulation
- Beam and latch: Intracellular lever-like structures that transmit force from the blades to the pore gate
PIEZO2 is expressed in a highly cell-type-specific pattern in the nervous system:
- Dorsal root ganglion (DRG) neurons: Large-diameter Aβ mechanoreceptors for light touch and proprioception
- Trigeminal ganglion neurons: Facial and oral mechanoreception
- Merkel cells: Epidermal mechanoreceptors (Merkel cell-neurite complexes)
- Proprioceptors: Muscle spindle afferents and Golgi tendon organs
- Enteric neurons: Gut mechanosensation
- Brain: Low-level expression in hippocampus and cortex
PIEZO2 is the primary mechanotransducer for discriminative touch and proprioception:
- Light touch: Converts gentle skin deformation into electrical signals via rapidly adapting mechanically-gated currents
- Vibration detection: Detects high-frequency vibration (particularly 40-250 Hz Pacinian-range stimuli) through rapid inactivation kinetics
- Proprioception: In muscle spindle afferents, PIEZO2 senses muscle stretch, providing the brain with continuous information about limb position and movement
- Airway stretch sensing: PIEZO2 in pulmonary sensory neurons mediates the Hering-Breuer inflation reflex
PIEZO2 has distinctive biophysical properties:
- Rapid inactivation: Mechanically activated currents inactivate within milliseconds, enabling detection of dynamic stimuli
- Cation selectivity: Permeant to Na+, K+, and Ca2+ with moderate calcium permeability (PCa/PNa ~4.5)
- Force sensitivity: Activated by membrane tension, osmotic swelling, and direct pipette poking
- Modulation: Channel kinetics are modulated by STOML3 (stomatin-like protein 3), which enhances mechanosensitivity
PIEZO2 plays essential roles in nervous system development:
- Axon guidance: Mechanosensitive signaling through PIEZO2 influences growth cone navigation
- Neuronal migration: PIEZO2-mediated calcium transients guide neuronal positioning during cortical development
- Circuit refinement: Activity-dependent PIEZO2 signaling contributes to somatosensory circuit maturation
Gain-of-function PIEZO2 mutations cause distal arthrogryposis type 5:
- Joint contractures: Fixed flexion deformities of distal joints (fingers, toes)
- Limited eye movement: Restrictive ophthalmoplegia
- Mechanism: Gain-of-function mutations slow channel inactivation, leading to excessive mechanotransduction and sustained muscle contraction during development
- I802F, R2686H mutations: Slow inactivation kinetics 3-10 fold
Another gain-of-function PIEZO2 disorder:
- Distal arthrogryposis: Similar to DA5 with joint contractures
- Cleft palate: Orofacial involvement
- Short stature: Growth restriction
- Ptosis: Eyelid drooping
Biallelic loss-of-function PIEZO2 mutations cause a distinctive neurological syndrome:
- Absent proprioception: Complete loss of body position sense, leading to sensory ataxia — patients cannot stand with eyes closed (positive Romberg sign) and have severely impaired joint position sense
- Loss of light touch: Inability to detect gentle skin contact, with preserved pain and temperature sensation
- Absent vibration sense: Complete loss of vibratory perception
- Normal pain: Nociceptive pathways (mediated by TRPV1 and other channels) remain intact
- Hip dysplasia: Developmental skeletal abnormalities
- Progressive scoliosis: Spinal deformity from proprioceptive denervation
- Motor coordination: Remarkably, patients develop compensatory strategies using vision and vestibular input
PIEZO2 intersects with neurodegeneration through several mechanisms:
- Sensory neuronopathy: PIEZO2-expressing large-diameter DRG neurons are preferentially lost in certain sensory neurodegenerative conditions, and PIEZO2 dysfunction may contribute to proprioceptive decline in aging
- Microglial mechanosensing: Microglia express mechanosensitive channels and respond to tissue stiffness changes. While PIEZO1 is the dominant microglial mechanosensor, PIEZO2 may contribute to mechanosensitive inflammatory signaling in the brain
- Amyloid-beta and tissue stiffness: Amyloid plaque deposition alters brain tissue mechanics. Mechanosensitive signaling through Piezo channels may transduce these mechanical changes into cellular responses
- Peripheral neuropathy in AD/PD: Proprioceptive deficits and gait instability in Alzheimer's disease and Parkinson's disease may partly reflect PIEZO2-expressing neuron dysfunction in DRG
- Age-dependent decline: Touch sensitivity and proprioception decline with aging, potentially reflecting age-related changes in PIEZO2 expression or function
- Yoda1: Selective PIEZO1 agonist (does not activate PIEZO2), used as research tool
- Jedi1/Jedi2: Non-selective Piezo channel activators
- GsMTx4: Spider venom peptide that inhibits mechanosensitive channels including PIEZO2
- Ruthenium red: Non-selective blocker of mechanosensitive channels
- Gain-of-function therapeutic targeting: For DA5/Gordon syndrome, PIEZO2 inhibitors could potentially reduce excessive mechanotransduction
- PIEZO2 deficiency: Gene replacement therapy for PIEZO2 loss-of-function is challenging due to the enormous gene size (~8.5 kb cDNA)
- ASO approaches: Antisense oligonucleotides to modulate PIEZO2 splicing in gain-of-function disorders
- Understanding PIEZO2 biology informs rehabilitation strategies for proprioceptive loss in neurodegenerative diseases
- Vibration therapy and proprioceptive training paradigms target PIEZO2-mediated pathways
- Coste et al. (2010) discovered PIEZO1 and PIEZO2 as mechanically activated ion channels
- Ranade et al. (2014) demonstrated PIEZO2 as the principal mechanotransducer for light touch sensation
- Woo et al. (2015) identified PIEZO2 as essential for proprioception in mice
- Chesler et al. (2016) characterized the human PIEZO2 deficiency syndrome with absent proprioception and touch
- Ge et al. (2015) determined the cryo-EM structure of mouse PIEZO2, revealing its trimeric propeller architecture